Designing Protein Contrast Agents for Precision MR Imaging (pMRI)

Conclusions: ProCAs exhibit super metal safety compared with all approved "safe" agents. Rapid development of pMRI platform technology and regulatory studies of ProCAs are expected to enable us to non-invasively determine the identity, quantity, and spatial location of the several major cancer cell types and their contribution to the heterogeneity of a tumor and its microenvironment. This will fill in the major gap with high translational capability which will have broad applications in medical diagnostics for early detection, monitoring progression, image-guided intervention, and drug development.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: Preclinical Probes for Oncology Posters Source Type: research